1194PTranslational endpoints in patients with metastatic microsatellite-stable colorectal cancer (MSS-CRC) treated with durvalumab plus monalizumab (anti-NKG2A). (23rd October 2018) - Diamond, J R; Standifer, N; Ascierto, M L; Morehouse, C; Ghadially, H; Rodriguez Canales, J; Rebelatto, M C; Naidoo, J; Mazzarella, L; Patel, S; Flor Oncala, M J; Alonso Gordoa, T; et al.